Over 100,000 Registered for Dysport Challenge

The maker of the wrinkle treatment Dysport® announced that over 100,000 people have registered for the  Dysport® Challenge. The challenge, which began in March, allows patients to save $75 when they try Dysport®. If they “love it,” patients may receive $75 off their next Dysport® treatment; if they don’t, patients receive a $75 rebate off another botulinum toxin type A product, such as BOTOX®.

Between March 1 and May 9, 2010, 91.2 percent of 22,416 patients who made a selection chose “Love It,” according to Medicis, the maker of Dysport®.

So far, only 2.6 percent of all registered patients have made a selection to “Leave It” since the program began.

Dysport® was approved by the FDA in April 2009 to treat severe frown lines between the eyebrows—the first competitor to BOTOX® in the U.S.

Dysport® works by blocking the nerve impulses of tiny muscles that cause wrinkles in the face, allowing them to flatten out and become less visible.

“We are pleased to announce this tremendous support by both physicians and patients for the Dysport® Challenge,” said Jonah Shacknai, Chairman and Chief Executive Officer of Medicis. “Medicis made a bold statement of confidence in the brand by offering patients the opportunity to try Dysport® and save up to $150 total.”

The Dysport® Challenge runs through the end of September 2010 and is open to patients 18 and older. For complete challenge details, visit www.Dysport®USA.com. Dr. Branman offers Dysport® at his Cosmetic Surgery Center in Little Rock, Arkansas .